Immediate Impact

2 by Nobel laureates 3 from Science/Nature 53 standout
Sub-graph 1 of 24

Citing Papers

Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial
2021 Standout
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
2020 Standout
3 intermediate papers

Works of R. M. Stone being referenced

Torsades de pointes associated with voriconazole use
2007
Phase 1 Study of PKC412, an Oral FLT3 Kinase Inhibitor, in Sequential and Concomitant Combinations with Daunorubicin and Cytarabine (DA) Induction and High-Dose Cytarabine (HDAra-C) Consolidation in Newly Diagnosed Patients with AML.
2004

Author Peers

Author Last Decade Papers Cites
R. M. Stone 188 126 59 13 296
Masaki Toshima 142 155 63 16 325
Alun Parsons 148 169 45 18 294
Haytham Khoury 102 125 53 15 294
Kira Behrens 158 163 49 9 294
Richard Broekhuizen 138 139 38 10 301
Mark Velangi 150 81 62 17 233
Esther Schuler 167 56 78 20 258
RS Weinberg 197 187 87 11 319
Giovanni Rossi 140 71 59 24 257
Edouard Randriamalala 225 140 50 13 327

All Works

Loading papers...

Rankless by CCL
2026